SEC Form 4 · Rule 10b5-1 trading plans
INSMED Inc (INSM)
- 108Trades filed under a plan
- 6Plan adoption dates stated
- 7Quarterly results prints on file
- 12Trades in the days before a print
In the 2025 filing year, INSMED Inc filed 29 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 7 reporting owners, covering 108 transactions filed under those plans and 998,099 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 29 names a plan in a footnote. 7 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in INSMED Inc 108
- Lewis William — 2025-01-02 · S · 18,750 shares
- Lewis William — 2025-01-02 · S · 6,830 shares
- Adsett Roger — 2025-01-07 · S · 2,444 shares
- Flammer Martina M.D. — 2025-01-07 · S · 3,344 shares
- Schaeffer Orlov S Nicole — 2025-01-07 · S · 2,596 shares
- Wise John Drayton — 2025-01-07 · S · 10,000 shares
- Wise John Drayton — 2025-01-07 · S · 2,908 shares
- Adsett Roger — 2025-01-08 · S · 1,882 shares
- Flammer Martina M.D. — 2025-01-08 · S · 1,702 shares
- Schaeffer Orlov S Nicole — 2025-01-08 · S · 1,209 shares
- Wise John Drayton — 2025-01-08 · S · 392 shares
- Adsett Roger — 2025-01-10 · S · 1,298 shares
Plan adoption dates stated in INSMED Inc 6
- 2024-06-07 — stated in 1 filing
- 2024-08-15 — stated in 1 filing
- 2024-09-12 — stated in 4 filings
- 2025-02-27 — stated in 3 filings
- 2025-03-05 — stated in 2 filings
- 2025-06-13 — stated in 1 filing
Quarterly results prints on file in INSMED Inc 7
- 2025-02-20
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-02-19
- 2026-05-07
- 2026-08-06
Trades in the days before a print in INSMED Inc 12
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Bonstein Sara · 17,622 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Bonstein Sara · 700 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 1,253 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 16,743 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 754 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 456 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 6,074 shares
- 2 days before the 2025-02-20 print — 2025-02-18 · S · Lewis William · 300 shares
- 3 days before the 2025-08-07 print — 2025-08-04 · S · Flammer Martina M.D. · 8,715 shares
- 3 days before the 2025-08-07 print — 2025-08-04 · S · Lewis William · 1,693 shares
- 3 days before the 2025-08-07 print — 2025-08-04 · S · Lewis William · 3,199 shares
- 3 days before the 2025-08-07 print — 2025-08-04 · S · Lewis William · 1,938 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 12Within 5 days of a print
- 20Within 10 days of a print
- 2Shortest interval, in days
- 0Trades with no later print on file
- Adsett Roger 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Operating Officer
- Adsett Roger 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Operating Officer
- Adsett Roger 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Operating Officer
- Flammer Martina M.D. 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Medical Officer
- Flammer Martina M.D. 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Medical Officer
- Flammer Martina M.D. 2025-02-10 · S · 10 days before the 2025-02-20 print · Chief Medical Officer
- Bonstein Sara 2025-02-11 · S · 9 days before the 2025-02-20 print · Chief Financial Officer
- Bonstein Sara 2025-02-12 · S · 8 days before the 2025-02-20 print · Chief Financial Officer
- Bonstein Sara 2025-02-18 · S · 2 days before the 2025-02-20 print · Chief Financial Officer
- Bonstein Sara 2025-02-18 · S · 2 days before the 2025-02-20 print · Chief Financial Officer
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Lewis William 2025-02-18 · S · 2 days before the 2025-02-20 print · Chair and CEO
- Flammer Martina M.D. 2025-08-04 · S · 3 days before the 2025-08-07 print · Chief Medical Officer
- Lewis William 2025-08-04 · S · 3 days before the 2025-08-07 print · Chair and CEO
- Lewis William 2025-08-04 · S · 3 days before the 2025-08-07 print · Chair and CEO
- Lewis William 2025-08-04 · S · 3 days before the 2025-08-07 print · Chair and CEO
Adoption dates, as the filings state them
- 2024-06-07 stated in 1 filing
- 2024-08-15 stated in 1 filing
- 2024-09-12 stated in 4 filings
- 2025-02-27 stated in 3 filings
- 2025-03-05 stated in 2 filings
- 2025-06-13 stated in 1 filing
As the filings state it: “10b5-1 trading plan adopted by the Reporting Person on February 27, 2025”
Reported results dates on file
- 2025-02-20
- 2025-05-08
- 2025-08-07
- 2025-10-30
- 2026-02-19
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.